Philanthropy scale Curebound is a rapidly growing cancer research philanthropy with ambitious plans to invest $100 million over the next decade, backed by a track record of over $43 million raised and 142 funded initiatives, signaling strong fundraising momentum and potential for major donor partnerships.

Leadership momentum Recent executive additions including Chief Advancement Officer, Chief Scientific Officer, CFO, and Board Chair indicate a strategic refresh and increased governance, creating multiple entry points for high-level partnerships, sponsorships, and aligned corporate philanthropy programs.

Local collaboration Strong San Diego research ecosystem involvement (UC San Diego Health, Salk Institute, La Jolla Institute, Scripps, etc.) offers a ready-made network for joint grant programs, sponsor engagements, and co-branded fundraising initiatives with regional institutions.

High-impact pillars Funding focus on prevention, immunotherapies, personalized vaccines, pediatric cancers, and addressing disparities aligns with strategic donor interests in cutting-edge therapies, equity, and population health, creating tailored pitches for foundations and corporate sponsors seeking impact areas.

Tech-enabled outreach Adopted tech stack including Salesforce, AWS, Braze, and marketing tools suggests scalable donor engagement, data-driven fundraising campaigns, and individualized stewardship opportunities that can be leveraged in enterprise sponsorship proposals and digital fundraising collaborations.